IMV Inc. (IMVIQ)
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
Address
130 EILEEN STUBBS AVE.
DARTMOUTH, A5 B3B 2C4
Founded
2007
Number of Employees
-
Website
http://www.imv-inc.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)